Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MYGN · against 1,372 other Healthcare companies
Ranked #1,140 of 1,373 · scores higher than 17% of peers · safety percentile 17
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 10–19, including MYGN · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MYGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.69× | 0.24× | 23% | 33% | |
| BetaLower is better · 1,320 reported | 1.68 | 0.53 | 8% | 33% | |
| Current ratioHigher is better · 1,338 reported | 2.21× | 2.62× | 44% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,136 | 2.8B USD | 17 | 33 | |
| 1,137 | 1.5B EUR (≈$1.6B) | 17 | 44 | |
| 1,138 | 725M USD | 17 | 19 | |
| 1,139 | 22.3B SEK (≈$2.2B) | 17 | 36 | |
| 1,140 | 578M USD | 17 | 22 | |
| 1,141 | 4.7B GBP (≈$6.1B) | 17 | 49 | |
| 1,142 | 2.2B USD | 17 | 37 | |
| 1,143 | 379.9B INR (≈$4.6B) | 17 | 55 | |
| 1,144 | 1.18T KRW (≈$847M) | 17 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score